Inicio
Información del autor
Autor Arbey Aristizabal Álzate
Comentario :
Médico Internista Nefrólogo, Hospital Pablo Tobón Uribe
|
Documentos disponibles escritos por este autor (51)
Refinar búsqueda
Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 / Lina Maria Serna Higuita ; John Fredy Nieto Ríos ; Catalina Ocampo Kohn ; Arbey Aristizabal Álzate ; Catalina Vélez Echeverri ; Juan José Vanegas Ruiz ; Isabel Cristina Ramírez Sánchez ; John Jairo Zuleta Tobón ; Gustavo Adolfo Zuluaga Valencia
Título : Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 Tipo de documento : documento electrónico Autores : Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Catalina Vélez Echeverri, ; Juan José Vanegas Ruiz, ; Isabel Cristina Ramírez Sánchez, ; John Jairo Zuleta Tobón, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2014 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Graft rejection kidney transplantation mycobacterium tuberculosis Resumen : Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. Mención de responsabilidad : Lina Maria Serna Higuita, John Fredy Nieto-Ríos, Salomon Daguer-Gonzalez, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Catalina Velez-Echeverri, Juan Jose Vanegas-Ruiz, Isabel Ramirez-Sanchez, Jhon Jairo Zuleta Tobon, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2014 Oct-Dec;36(4):512-8. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140073 PMID : 25517281 Derechos de uso : CC BY-NC En línea : http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&l [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4546 Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 [documento electrónico] / Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Catalina Vélez Echeverri, ; Juan José Vanegas Ruiz, ; Isabel Cristina Ramírez Sánchez, ; John Jairo Zuleta Tobón, ; Gustavo Adolfo Zuluaga Valencia, . - 2014.
Obra : Brazilian Journal of Nephrology
Idioma : Inglés (eng)
Palabras clave : Graft rejection kidney transplantation mycobacterium tuberculosis Resumen : Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. Mención de responsabilidad : Lina Maria Serna Higuita, John Fredy Nieto-Ríos, Salomon Daguer-Gonzalez, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Catalina Velez-Echeverri, Juan Jose Vanegas-Ruiz, Isabel Ramirez-Sanchez, Jhon Jairo Zuleta Tobon, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2014 Oct-Dec;36(4):512-8. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140073 PMID : 25517281 Derechos de uso : CC BY-NC En línea : http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&l [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4546 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001043 AC-2014-114 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2014-114.pdfAdobe Acrobat PDF Sickle cell crisis and acute humoural rejection in kidney graft / John Fredy Nieto Ríos ; Lina Maria Serna Higuita ; Gustavo Adolfo Zuluaga Valencia ; Arbey Aristizabal Álzate ; Catalina Ocampo Kohn
Título : Sickle cell crisis and acute humoural rejection in kidney graft Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Lina Maria Serna Higuita, ; Gustavo Adolfo Zuluaga Valencia, ; Arbey Aristizabal Álzate, ; Catalina Ocampo Kohn, Fecha de publicación : 2013 Títulos uniformes : Nefrología Idioma : Inglés (eng) Mención de responsabilidad : John F Nieto-Ríos, Lina M Serna-Higuita, Ana K Serrano-Gayubo, Arbey Aristizabal-Alzate, Catalina Ocampo-Kohn, Rafael Andrade-Pérez, Gustavo Zuluaga-Valencia Referencia : Nefrologia. 2013;33(2):286-8. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Oct.11760 PMID : 23511772 Derechos de uso : CC BY-NC-ND En línea : https://www.revistanefrologia.com/es-linkresolver-crisis-falciforme-rechazo-agud [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3717 Sickle cell crisis and acute humoural rejection in kidney graft [documento electrónico] / John Fredy Nieto Ríos, ; Lina Maria Serna Higuita, ; Gustavo Adolfo Zuluaga Valencia, ; Arbey Aristizabal Álzate, ; Catalina Ocampo Kohn, . - 2013.
Obra : Nefrología
Idioma : Inglés (eng)
Mención de responsabilidad : John F Nieto-Ríos, Lina M Serna-Higuita, Ana K Serrano-Gayubo, Arbey Aristizabal-Alzate, Catalina Ocampo-Kohn, Rafael Andrade-Pérez, Gustavo Zuluaga-Valencia Referencia : Nefrologia. 2013;33(2):286-8. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Oct.11760 PMID : 23511772 Derechos de uso : CC BY-NC-ND En línea : https://www.revistanefrologia.com/es-linkresolver-crisis-falciforme-rechazo-agud [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3717 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000290 AC-2013-058 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2013-058.pdfAdobe Acrobat PDF Histoplasmosis diseminada y síndrome hemofagocítico en dos pacientes trasplantados renales / John Fredy Nieto Ríos ; Arbey Aristizabal Álzate ; Catalina Ocampo Kohn ; Lina Maria Serna Higuita ; Gustavo Adolfo Zuluaga Valencia
Título : Histoplasmosis diseminada y síndrome hemofagocítico en dos pacientes trasplantados renales Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Arbey Aristizabal Álzate, ; Catalina Ocampo Kohn, ; Lina Maria Serna Higuita, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2012 Títulos uniformes : Nefrología Idioma : Español (spa) Mención de responsabilidad : Jhon F Nieto-Ríos, Arbey Aristizabal-Alzate, Catalina Ocampo, Ana K Serrano-Gayubo, Lina M Serna-Higuita, Gustavo Zuluaga-Valencia Referencia : Nefrologia. 2012;32(5):683-4. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Jun.11508 PMID : 23013962 En línea : http://www.revistanefrologia.com/es/linksolver/ft/ivp/0211-6995/32/683 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4496 Histoplasmosis diseminada y síndrome hemofagocítico en dos pacientes trasplantados renales [documento electrónico] / John Fredy Nieto Ríos, ; Arbey Aristizabal Álzate, ; Catalina Ocampo Kohn, ; Lina Maria Serna Higuita, ; Gustavo Adolfo Zuluaga Valencia, . - 2012.
Obra : Nefrología
Idioma : Español (spa)
Mención de responsabilidad : Jhon F Nieto-Ríos, Arbey Aristizabal-Alzate, Catalina Ocampo, Ana K Serrano-Gayubo, Lina M Serna-Higuita, Gustavo Zuluaga-Valencia Referencia : Nefrologia. 2012;32(5):683-4. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Jun.11508 PMID : 23013962 En línea : http://www.revistanefrologia.com/es/linksolver/ft/ivp/0211-6995/32/683 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4496 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000995 AC-2012-084 Archivo digital Producción Científica Artículos científicos Disponible Nefritis tubulointersticial y colangitis esclerosante asociadas a pancreatitis autoinmune / Arbey Aristizabal Álzate ; Carolina Muñoz Grajales ; Catalina Ocampo Kohn ; John Fredy Nieto Ríos ; Gustavo Adolfo Zuluaga Valencia
Título : Nefritis tubulointersticial y colangitis esclerosante asociadas a pancreatitis autoinmune Tipo de documento : documento electrónico Autores : Arbey Aristizabal Álzate, ; Carolina Muñoz Grajales, ; Catalina Ocampo Kohn, ; John Fredy Nieto Ríos, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2012 Títulos uniformes : Nefrología Idioma : Español (spa) Mención de responsabilidad : Arbey Aristizabal-Alzate, Carolina Muñoz-Grajales, Catalina Ocampo-Kohn, John F Nieto-Ríos, Gustavo A Zuluaga-Valencia Referencia : Nefrologia. 2012;32(6):854-6. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Aug.11185 PMID : 23169380 Derechos de uso : CC BY-NC-ND En línea : http://www.revistanefrologia.com/es/linksolver/ft/ivp/0211-6995/32/854 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4489 Nefritis tubulointersticial y colangitis esclerosante asociadas a pancreatitis autoinmune [documento electrónico] / Arbey Aristizabal Álzate, ; Carolina Muñoz Grajales, ; Catalina Ocampo Kohn, ; John Fredy Nieto Ríos, ; Gustavo Adolfo Zuluaga Valencia, . - 2012.
Obra : Nefrología
Idioma : Español (spa)
Mención de responsabilidad : Arbey Aristizabal-Alzate, Carolina Muñoz-Grajales, Catalina Ocampo-Kohn, John F Nieto-Ríos, Gustavo A Zuluaga-Valencia Referencia : Nefrologia. 2012;32(6):854-6. DOI (Digital Object Identifier) : 10.3265/Nefrologia.pre2012.Aug.11185 PMID : 23169380 Derechos de uso : CC BY-NC-ND En línea : http://www.revistanefrologia.com/es/linksolver/ft/ivp/0211-6995/32/854 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4489 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000989 AC-2012-078 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2012-078.pdfAdobe Acrobat PDF Clinical description and evolution of renal transplant pediatric patients treated with alemtuzumab / Catalina Vélez Echeverri ; Gustavo Adolfo Zuluaga Valencia ; Catalina Ocampo Kohn ; Arbey Aristizabal Álzate ; Lina Maria Serna Higuita ; John Jairo Zuleta Tobón ; Juan José Vanegas Ruiz
Título : Clinical description and evolution of renal transplant pediatric patients treated with alemtuzumab Tipo de documento : documento electrónico Autores : Catalina Vélez Echeverri, ; Gustavo Adolfo Zuluaga Valencia, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Lina Maria Serna Higuita, ; John Jairo Zuleta Tobón, ; Juan José Vanegas Ruiz, Fecha de publicación : 2011 Títulos uniformes : Transplantation Proceedings Idioma : Francés (fre) Idioma original : Inglés (eng) Resumen : Background: Renal transplantation is the most effective treatment for children with end-stage renal disease. Recent work suggests that induction with alemtuzumab in the pediatric population permits the use of lower doses of maintenance immunosuppressive therapy. In addition, it has a low cost compared with other induction therapies. Objective: To conduct a clinical description of pediatric renal transplant patients comparing induction protocols to evaluate graft and patient survival, infections complications, and lymphoproliferative diseases. Materials and Methods. This descriptive and retrospective study, of evaluated pediatric renal transplant patients between 2006 and 2010. Results: The agents for induction therapy were: alemtuzumab (61.5%), daclizumab (19.25%), and thymoglobulin (19.25%). Graft survival was better among the alemtuzumab group (87.5%) compared with the other two induction therapies (80%). The frequency of acute rejection episodes during the first year posttransplantation as well as chronic rejection was lower among the alemtuzumab group. Cytomegalovirus infection was noted in 30% of patients with greater frequency among those induced with alemtuzumab. Conclusion: Induction therapy with alemtuzumab was safe in a pediatric population not predisposing to a greater risk of acute or chronic rejection. Except for a greater incidence of Cytomegalovirus, there was no difference in other complications. Mención de responsabilidad : C Velez, G Zuluaga, C Ocampo, A Aristizabal, L M Serna, A K Serrano Gayubo, J A Florez, J J Zuleta, J J Vanegas Ruiz Referencia : Transplant Proc. 2011 Nov;43(9):3350-4. DOI (Digital Object Identifier) : 10.1016/j.transproceed.2011.09.101 PMID : 22099794 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0041-1345(11)01380-7 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3583 Clinical description and evolution of renal transplant pediatric patients treated with alemtuzumab [documento electrónico] / Catalina Vélez Echeverri, ; Gustavo Adolfo Zuluaga Valencia, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Lina Maria Serna Higuita, ; John Jairo Zuleta Tobón, ; Juan José Vanegas Ruiz, . - 2011.
Obra : Transplantation Proceedings
Idioma : Francés (fre) Idioma original : Inglés (eng)
Resumen : Background: Renal transplantation is the most effective treatment for children with end-stage renal disease. Recent work suggests that induction with alemtuzumab in the pediatric population permits the use of lower doses of maintenance immunosuppressive therapy. In addition, it has a low cost compared with other induction therapies. Objective: To conduct a clinical description of pediatric renal transplant patients comparing induction protocols to evaluate graft and patient survival, infections complications, and lymphoproliferative diseases. Materials and Methods. This descriptive and retrospective study, of evaluated pediatric renal transplant patients between 2006 and 2010. Results: The agents for induction therapy were: alemtuzumab (61.5%), daclizumab (19.25%), and thymoglobulin (19.25%). Graft survival was better among the alemtuzumab group (87.5%) compared with the other two induction therapies (80%). The frequency of acute rejection episodes during the first year posttransplantation as well as chronic rejection was lower among the alemtuzumab group. Cytomegalovirus infection was noted in 30% of patients with greater frequency among those induced with alemtuzumab. Conclusion: Induction therapy with alemtuzumab was safe in a pediatric population not predisposing to a greater risk of acute or chronic rejection. Except for a greater incidence of Cytomegalovirus, there was no difference in other complications. Mención de responsabilidad : C Velez, G Zuluaga, C Ocampo, A Aristizabal, L M Serna, A K Serrano Gayubo, J A Florez, J J Zuleta, J J Vanegas Ruiz Referencia : Transplant Proc. 2011 Nov;43(9):3350-4. DOI (Digital Object Identifier) : 10.1016/j.transproceed.2011.09.101 PMID : 22099794 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0041-1345(11)01380-7 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3583 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000153 AC-2011-038 Archivo digital Producción Científica Artículos científicos Disponible Induction therapies in kidney transplantation: the experience of Hospital Pablo Tobon Uribe, Medellín, Colombia 2005-2010 / Catalina Ocampo Kohn ; Arbey Aristizabal Álzate ; John Fredy Nieto Ríos ; Harry Abadía Guzmán ; Walter Mario Ángel Jaramillo ; Carlos Ernesto Guzmán Luna ; Álvaro Mena Hurtado ; Juan José Vanegas Ruiz ; Catalina Vélez Echeverri ; Carlos Enrique Yepes Delgado ; Gustavo Adolfo Zuluaga ValenciaPermalink